1980
DOI: 10.1016/0033-0620(80)90027-4
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular disease in patients on chronic hemodialytic therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
12
0

Year Published

1983
1983
2012
2012

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(12 citation statements)
references
References 65 publications
0
12
0
Order By: Relevance
“…Nevertheless the potential causes of impaired contractility during the peritransplant period include chronic hypertension [20], hemodialysis, iron overload [21] and volume overload injury [22], The peak late transmitral velocity reduc tion and the slight increase in the E/A ratio we observed may reflect an improvement in LV relaxation [23] in patients with lower BP at follow-up. We hypothesize that peak late transmitral velocity reduction could be an early marker of diastolic function improve ment after RT.…”
mentioning
confidence: 85%
“…Nevertheless the potential causes of impaired contractility during the peritransplant period include chronic hypertension [20], hemodialysis, iron overload [21] and volume overload injury [22], The peak late transmitral velocity reduc tion and the slight increase in the E/A ratio we observed may reflect an improvement in LV relaxation [23] in patients with lower BP at follow-up. We hypothesize that peak late transmitral velocity reduction could be an early marker of diastolic function improve ment after RT.…”
mentioning
confidence: 85%
“…Although oximetry was not carried out in our patient population, other studies suggest that HD can provoke significant tissue hypoxemia [24,25], This would be a possible mechanism whereby a myocardial oxygen supply deficit could occur. Other possi ble mechanisms include hypoventilation, anemia, coro nary vasospasm, or enhanced platelet activation [26,27], Although this is the first study to look at EF during HD, at least one study has looked at EF before and after HD using radionuclide scintigraphic techniques [28]. In this study, patients with normal hearts had a mean improvement in EF of 12.9 ± 4.4%, while those with heart disease had a mean decrease in EF of 2.3 ± 8.1%.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiac failure is common in patients with end-stage renal disease (ESRD) [2]. In addition to direct myocardial depression from a circulating toxin associated with uremia, chronic renal failure has the potential to cause myocardial dysfunction through chronic hypertension [3], premature atherosclerosis due to abnormal carbohydrate and lipid metabolism [4], cardiomyopathy associated with iron overload [5] and volume overload injury due to chronic anemia, hypervolemia, and iatrogenic arteriovenous fistulas [6,7]. …”
Section: Introductionmentioning
confidence: 99%